PS01.59: CheckMate 370: A Master Protocol of Phase 1/2 Studies of Nivolumab as Maintenance or First-Line ± Standard-of-Care Therapies in Advanced NSCLCGeorge R. Blumenschein, Craig H. Reynolds, Jason C. Chandler et al.|Journal of Thoracic Oncology|2016Cited by 5
Abound.Sqm: a Phase 3 Randomized Study of Maintenance Nab-Paclitaxel (Nab-P) After Induction Therapy with Nab-P Plus Carboplatin (C) in Patients (Pts) with Squamous Cell (Scc) Non-Small Cell Lung Cancer (Nsclc)David R. Spigel, Craig H. Reynolds, E. Kim et al.|Annals of Oncology|2014Cited by 2